Market Research Blog

According to a new market study by Future Market Insights (FMI), the medical cannula market is forecasted to expand at a healthy CAGR of 7.3% in 2030. Cannula is a flexible tube with a retractable and sharp inner core which is inserted into a vein or an artery or in other body cavities of a patient in order to remove or delivery of fluids for treatment or medical investigational procedures like infusing medication or obtaining blood samples

According to the National Center for Biotechnology Information (NCBI), over 234 Mn surgeries are conducted every year globally and the number continues to increase annually. This is expected to play a crucial role in the growth of the global medical cannula market for the years to come.

Medical cannula finds adoption in applications associated with surgeries such as the delivery of therapeutic & diagnostic agents, anesthetic procedures, suction, and irrigation. Along similar lines, inclination among patients towards minimally invasive surgeries is further fuelling the demand for medical cannula.

Furthermore, the patient-pool suffering from cardiovascular disorders and other chronic diseases such as diabetes and hypertension is proliferating, thereby necessitating medical cannula in treatment. This will continue to drive the global medical cannula market on a remunerative path through the forecast period.

“Market players across the globe are tapping on the demand among diabetes patients. Moreover, the outbreak of Covid-19 is catalyzing the growth of the market and the uptrend is expected to prevail through the first two quarters of 2021”, says FMI analyst.

Request a Sample Report @

https://www.futuremarketinsights.com/reports/sample/rep-gb-1057

Medical Cannula Market – Key Takeaways

• Advent of technologies has enabled effective clinical usage of medical cannulae, thereby boosting the growth of the market
• Among types of products intravenous(IV) is expected to remain the most sought-out product, accounting for around 3/4th of global market value.
• Vascular access treatment is projected to hold nearly 30% of the revenue share through the forecast period.
• Based on sizes, the 18G segment is anticipated to account for nearly 50% of market share, while 20G segment follow closely.

Medical Cannula Market – Key Trends

• Shifting preference towards minimally-invasive medical procedures is opening new avenues for market growth.
• Outbreak of Covid-19 has increased the demand for medical cannula among healthcare institutions and is acting as a catalyst.

Medical Cannula Market – Regional Analysis

• North America is forecasted to spearhead the regional landscape owing to the presence of a strong healthcare sector coupled with a high approval rate of drugs and novel products.
• Europe will remain the second-largest regional market backed by high spending on healthcare.
• Emerging economies such as Asia Pacific and Latin America are projected to metamorphose into prominent regions through the forecast period on the back of the expanding healthcare services in these regions.

Medical Cannula Market – Competitive Landscape

Some of the key players operating in the market include Medtronic plc, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Teleflex Incorporated, Conmed Corporation, B. Braun Melsungen AG., Smith & Nephew, Getinge AB, Ypsomed Holding AG, Terumo Corporation, and Harsoria Healthcare Pvt. Ltd. Market players are focusing on expanding their product portfolio by launching new products to gain a competitive edge. On these lines,

• In May 2020, Medtronic plc MDT announced a novel kind of cannula to address balloon kyphoplasty surgeries all over the US.
• In June 2020, LivaNova PLC’s cannula named B-Flow ECMO cannula procured CE Mark approval to conduct ECMO procedures having received approval in 2019 for cardiovascular surgeries.

Speak to our Research Expert @

https://www.futuremarketinsights.com/ask-question/rep-gb-1057

Key Segments of Medical Cannula Industry Survey

Medical Cannula Market by Product:

• Guedel
• Yankauer
• Berman
• Frazier
• Spackmann
• Barron
• Novak
• Poole
• Robertazzi
• Bellucci
• Brackman
• Karman
• Others

Medical Cannula Market by Medical Procedure:

• Vascular Access
• Surgery
• Intubation
• Lipofilling
• Suction
• Irrigation
• Biopsy
• Insufflation
• Hysterography
• Insemination
• Cardioplegia

Medical Cannula Market by Size:

• 14G Medical Cannulas
• 16G Medical Cannulas
• 18G Medical Cannulas
• 20G Medical Cannulas
• 22G Medical Cannulas
• 24G Medical Cannulas
• 26G Medical Cannulas

Medical Cannula Market by Material:

• Latex Medical Cannulas
• Latex-free Medical Cannulas
• Neoprene Medical Cannulas

Medical Cannula Market by End User:

• Hospitals
• Ambulatory Surgical Center
• Clinics
• Others

Medical Cannula Market by Region:

• North America Medical Cannula Market
• Latin America Medical Cannula Market
• Europe Medical Cannula Market
• East Asia Medical Cannula Market
• South Asia & Pacific Medical Cannula Market
• Middle East & Africa (MEA) Medical Cannula Market

Get Valuable Insights into the Medical Cannula Market

Future Market Insights, in its new offering, provides an unbiased analysis of the global medical cannula market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2020-2030. The study divulges compelling insights on the medical cannula market, allowing readers to glean qualitative and quantitative information which will enable them to make informed market decisions in the upcoming forecast period.

Report Customization available @ 

https://www.futuremarketinsights.com/customization-available/rep-gb-1057

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

Increasing prevalence of sleep disorders, especially in the U.S. and other European countries, creates lucrative growth opportunities for the sleep testing respiratory devices market. According to the National Healthy Sleep Awareness Project, around 25 million adults in the U.S. were suffering from sleep apnea.  Continuous focus on the market introduction of technologically advanced respiratory devices such as nebulizers, pulse oximeters and spirometers is expected to drive the respiratory devices market growth during the forecast period.

Rising prevalence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea has been increasing the demand for respiratory devices. Future Market Insights (FMI) in a new study has forecast the market to continue exhibiting high demand through 2031. While 2020 has proven exceptionally crucial to the market, growth will remain positive 2021 onwards, despite declining a little in comparison to remarkable sales recorded in 2020 amid COVID-19 outbreak.

Growing preference for smart or wearable respiratory devices over general respiratory devices in developed countries also creates a significant opportunity for global market players operating in the respiratory devices market. Adoption of portable devices for neonatal and adults suffering respiratory diseases is growing respiratory devices demand. For instance, Patients suffering from chronic respiratory diseases require continuous oxygen supply. A portable oxygen concentrator has several other benefits such as lightweight, small shape and easy to carry, which makes it the best choice of device.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-794

Hospitals are likely to remain chief end users of respiratory devices. They have been relentlessly offering patient care amid COVID-19 outbreak. Even as numbers of COVID-19 patients soared, healthcare centers around the world pushed through challenges to offer required care. Hospitals therefore accounted for a little above 40% of respiratory devices sold in 2020. By 2031, the number of respiratory devices sold in hospitals is expected to rise further.

Key Takeaways of Respiratory Devices Market Study

• Respiratory devices market will exhibit impressive growth through 2031. The market is forecast to exhibit 9.3% CAGR in 2021
• S. will remain the most lucrative market, accounting for almost 87% of respiratory devices sold in North America
• UK will exhibit impressive Y-o-Y growth at 10.5% in 2021
• Germany and France will continue exhibiting high demand for respiratory devices
• China and Korea will remain bright spots in East Asia market, however, Japan will remain dominant through the forecast period

Partnerships to Develop New Products – Imperative Strategy for Market Players

Leading manufacturers of the respiratory inhaler are focusing on strategic partnerships with software and digital companies to serve the selected population. Besides, such collaborations also help manufacturers improve their distribution channels as well as to launch their products. For instance, In June 2020, Medtronic plc entered into a partnership with Foxconn Industrial Internet to begin manufacturing Medtronic’s Puritan Bennett 560 (PB560) ventilators in the United States.

Similarly, Smith’s Medical has signed a distribution partnership with Medline Industries for distribution of the Portex acapella, a vibratory PEP therapy device to focus on the non-acute and home care channels in 2019.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-794

Key Segments

Product

• Respiratory Consumables
  • Respiratory Mask
  • Nasal Cannulas
  • Oxygen Tubing Sets
  • Breathing Filters
• Nebulizers
  • Compressed Jet Nebulizers
  • Ultrasonic Nebulizers
• Oxygen Concentrators
  • Home Oxygen Concentrators
  • Portable Oxygen
  • Concentrators`
• Positive Airway Pressure (PAP) Devices
• Polysomnography Devices
  • Ambulatory PSG Devices
  • Clinical PSG Devices
• Pulse Oximeters
• Mechanical Ventilators
• Spirometers

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-794

End Users

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Long Term Care Centers
• Others

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• The Middle East and Africa (MEA)
• Oceania

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[250 Pages Report] Sales of global manometry systems are expected to reach US$ 157.3 Mn in 2020. As per Future Market Insights, revenues for manometry systems are expected to reach US$ 279.6 Mn, expanding at a 5.4% CAGR over the forecast period (2021-2031).

Rise in number of people aged 65 years and older is expected to be the major factor boosting the growth of the manometry system market. In 2018, According to the U.S. Census Board people older than 65 years represent around 13% of the total population; this percentage is expected to reach 20% by 2031.

Rising cases of constipation, fecal incontinence, anorectal pain, pelvic floor dyssynergia and hirschsprung’s among older population is increasing the adoption of manometry systems. Demand for these systems helps evaluate patients and provides many useful data regarding anorectal function and indicates the prognosis of treatment, particularly in the management of sphincter injuries.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-14110

Rising demand for non-invasive equipment is driving the demand for manometry system. These systems are non-invasive diagnostic procedure that can detect pressures and sensation in the anus and rectum. With this, they indicate whether the patient’s pelvic function is normal without incision into the body or removal of tissue and has low risks, and complications.

Further, rising government initiatives and funding supporting the development of product is boosting the demand for manometry system market.  Initiatives undertaken by government to enable and boost the ecosystem for the indigenous medical device industry is also stimulating market growth.

“As demand for manometry systems is rising due to high prevalence of gastrointestinal diseases, key players are engaging in product development that is technologically advanced for faster approvals. This is expected to give the key players a competitive edge in the industry, generating revenues,” says the FMI Analyst

Key Takeaways from Manometry System Market Study

• By product, system sheath & catheters is expected to account for the largest share of 55.0% in 2021.
• In terms of portability, stand-alone system will hold for the largest share of 55.4% in 2021 on the back of its enhanced sensitivity to provide accurate diagnosis of condition
• By end user, hospitals accounted for the largest share of 37.9% in 2021 owing to the rising demand for hospital stay that is short-term and increasing number of gastrointestinal processes.
• North America is expected to hold largest share of 38.9% in 2021 with the U.S. leading the market during the forecast period.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14110

Who is Winning?

Some of the leading manufacturers of manometry system market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

Several joint ventures, agreements, and loan licensing procedures have influenced the market. The government of developing economies has taken several reforms to develop the market by regulating it to bring out more transparency and by allowing foreign investments in the industry.

New Product launches & approvals have emerged as key growth strategy adopted by the leading players in the manometry system market. Followed by this, acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand their regional presence as well as product offerings.

For instance,

• In October 2021, “UROTECH GmbH subsidiary of Medi-Globe Group’s provided detailed information on a new clinical study for using the Magnetic Black-Star® (MBS) in paediatric urology. The MBS was an innovative product of the UROTECH GmbH, which is used in stent placement as well as stent removal of children by without performing the surgeries using the stent’ magnetic tip.”
• In May 2020, RMS Medical Devices, proudly announced it’s the acquisition of QUICKORE products for BENELUX. With this new acquisition, RMS Medical Devices adds another premium technology to its Radiology portfolio.
• In October 2020, LABORIE Medical Technologies enters into strategic partnership with Urotronic to support regulatory approval of Optilume™, a drug-coated balloon (DCB) technology for use in urethral strictures and benign prostatic hyperplasia (BPH).

• In August 2021, Medtronic Announced the FDA Approval of Next-Gen TAVR System for the treatment of symptomatic severe aortic stenosis. Next-Gen TAVR System is a self-expanding transcatheter aortic valve replacement, which is designed to enhance ease-of-use and predictable valve deployment throughout the procedure.

The key market players covered by FMI include EB Neuro S.p.A, MEDSPIRA, Medtronic, Medica S.p.A., RMS Medical Devices, MARQUAT Génie Biomédical, Diversatek Inc., Dentsleeve International Ltd., LABORIE, Prometheus Group, Smart Medical Group, Synectics Medical Limited, Medovations Inc., Sierra Scientific, and Urotech Gmbh.

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-14110

Manometry System by Category

Product:

• Anorectal Manometry System
• Anorectal Manometry System Software
• Anorectal Manometry System Sheath & Catheters

Portability:

• Stand Alone System
• Portable System

End User:

• Hospitals
• Diagnostic Centers
• Speciality Clinics
• Academic Research Institutes

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), sales of home infusion therapy devices are expected to top US$ 2.0 Bn in 2021, growing at a CAGR of over 6.5% during the forecast period (2021-2031).

Home infusion therapy devices are used for the intravenous administration of medicines. It is commonly prescribed for patients with serious infections and specialized diseases when orally administered medicines are not or comparatively less effective.

Application of home infusion therapy devices is increasing with the rising number of surgeries conducted across the globe. Post-surgery pain management at home can be done with the help of home infusion therapy devices.

Besides this, rising healthcare expenditure and growing awareness regarding the risk and infection amidst the outbreak of COVID-19 is driving the demand of home infusion therapy devices.

Request Sample @– https://www.futuremarketinsights.com/reports/sample/rep-gb-13974

Key Takeaways from Home Infusion Therapy Devices Market Study

• By product type, infusion system accessories will hold around 45% of value share globally.
• Based on the application, antibiotic administration is leading with over 34% of the market share.
• Home care settings sales will dominate the home infusion therapy devices, with a market share of 65% during the forecast period.
• By region, the U.S. will dominate the global home infusion therapy devices market with a value share of around 37% during the forecast period.
• Followed by North America, Europe will be the second-largest leading region, with a value share of 93.2% during the forecast period.
• India is the dominant country in term of revenue for South Asia Home infusion therapy devices market, accounting for nearly 48% of market share in 2021.
• China holds leading position in East Asia and is expected to account for nearly 52% of market share.

“Growing prevalence of chronic diseases such as diabetes and cancer in the midst of COVID-19 pandemic and high risk of infection across hospitals encouraged key players to invest in new product launches. This is expected to enable growth in the market in the coming years” says a FMI Analyst.

Who is Winning?

Key players are focusing on new product launches and approvals. Other growth strategies adopted by leading players include, agreements, and collaborations among key manufacturers. By focusing on these strategies, key players are expanding their geographic presence and strengthening their existing product portfolio.

For instance,

• In June 2019, Baxter International Inc. announced that Myxredlin that is the first and only ready-to-use insulin for IV infusion get the US FDA approval.
• In Jan 2019, Fresenius Kabi AG launched two colourful bags via white spiral cables to supply the nutrient solution for parenteral nutrition.
• In April 2017, B. Braun Melsungen AG announced the launch of home infusion therapy App named Easypump® for healthcare professionals and patients.

The key market players profiled by FMI include Becton, Diciknson & Company, B.Braun Melsungen AG, Baxter International, Fresenius Kabi, Terumo Corporation, ICU Medical, Nipro Corporation, Smiths Medical, Micrel Medical Devices SA, Moog Inc., JMS Co.Ltd., Intera Oncology, and Others Top-up.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13974

Home Infusion Therapy Devices Market by Category By Product Type:

• Disposable Elastomeric Pumps
• Insulin Pumps
• PCA Pumps
• Electronic Ambulatory Pumps
• Infusion System Accessories

By Applications:

• Enteral Nutrition
• Parenteral Nutrition
• Chemotherapy
• Antibiotic Administration
• Others

By End User:

• Home Care Settings
• Long Term Care Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[269 Pages] The global biological and chemical indicators market is expected to reach $457.8 million in 2022, with a 7.2 percent CAGR indicating positive market growth over the forecast period.

The global biological and chemical indicators market is expected to reach $457.8 million in 2022, with a 7.2 percent CAGR indicating positive market growth over the forecast period.

According to Future Market Insights (FMI) the worldwide yearly tracker, vendor revenue in global biological & chemical indicators market will grow 9.1% year over year to 396.8 Mn in 2020. Global shipments will rise 9.7% year over year to 830.7 Mn units in 2020.

Irrespective of the COVID-19 pandemic, demand for biological and chemical indicators has been surging tremendously as sterilization has always been at forefront of duties of healthcare facilities.

However, the role will be put to test in near future as epidemiological numbers continue to rise amidst the public health crisis. As such, FMI foresees healthy growth trail for global biological and chemical indicators market over forecast period 2020-2030.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-12544

“After oral administration, parenteral dosage is the most prevalent way of providing drugs to patients. At present, about 95% of recently approved biopharmaceuticals are parenteral dosage form. This rise in commercialization and manufacturing of parenteral drugs will propel the adoption of biological and chemical indicators in biopharmaceuticals companies,” says analyst at FMI.

COVID-19 Impact on Biological & Chemical Indicators Market

The COVID-19 pandemic will trigger the demand for biological and chemical indicators for short-term to validate sterilization process in hospitals, ambulatory surgical centers (ASC), and clinics.

The pandemic has put pressure on frontline healthcare workers to follow strict cleaning and disinfection protocols as they are specifically at risk of contracting and spreading the infection. This has triggered the need for sterilization measures enacted during surgical procedures due to concerns of COVID-19 transmission among hospitalized patients.

The World Health Organization (WHO) has advised personal protective equipment (PPE) industry and governments to ramp up their manufacturing by 40% to cater to surging worldwide demand. This high pool of medical equipment with need for proper sterilization will bode well for biological & chemical indicators market in immediate future.

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12544

Biological & Chemical Indicators Market – Competitive Intelligence

The global biological & chemical indicators market is highly consolidated with top 5 players – 3M Company, Steris Plc., and Thermo Fisher – collectively accounting for around 4/5 of overall market revenue. In order to sustain competition due to increasing number of new and small companies, leading players are focusing on mergers and acquisitions (M&A). For instance,

• Thermo Fisher Scientific Inc. has acquired QIAGEN N.V. – leading worldwide provider of sample preparation and molecular diagnostics technologies. This acquisition will enable the company to leverage its industry-leading capabilities and R&D expertise to speed up innovation and deal with emerging healthcare needs.
• McKesson Medical-Surgical Inc. has entered into an agreement with Walgreens Boots Alliance to combine their respective pharmaceutical wholesale businesses in Germany.
• Cantel Medical has taken over Hu-Friedy, which manufactures dental instruments and reprocessing equipment.

Want to Know More About Biological & Chemical Indicators Market?

Future Market Insights, in its new study, provides compelling insights about the biological & chemical indicators market that encloses industry analysis for 2015 – 2019 and opportunity assessment for 2020 – 2030. The report offers unbiased assessment on biological & chemical indicators market through five different categories – sterilization type, indicator class, packaging form, end user, and region. The global biological & chemical indicators market research study delivers insights of pricing by different life cycle analysis, product life cycle, major market trends and technologies that are being utilized in the development of biological & chemical indicators and product adoption in various end users.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12544

Biological & Chemical Indicators Market Segmentation Sterilization Type

• Thermal Sterilization
  • Steam Heat
  • Dry Heat
• Chemical Sterilization
  • Ethylene Oxide
  • Hydrogen Peroxide
  • Formaldehyde
• Radiation Sterilization

Indicator Class

• Biological Indicators
  • Bacillus atrophaeus (BA) Spores
  • Geobacillus stearothermophilus (GS) Spores
  • Others
• Chemical Indicators
  • Class 1 (Process)
  • Class 4 (Multi-Variable)
  • Class 2 (Specific-Use)
  • Class 3 (Single-Variable)
  • Class 5 (Integrating)
  • Class 6 (Cycle Verification)
• Enzyme Indicators

Packaging Form

• Self-Contained BI
• Spore Suspension BI
• Strip and Disc BI
• Strip and Disc CI
• Others

End User

• Biopharma Industry
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Labs
• Research Labs

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs